| Literature DB >> 35610668 |
Lei Liu1, Fen Yan1, Lu Zhang1, Zhi-Feng Wu1, De-Yong Duan1, Tian-Yin Cheng2.
Abstract
BACKGROUND: Tick hemolymph bathes internal organs, acts as an exchange medium for nutrients and cellular metabolites, and offers protection against pathogens. Hemolymph is abundant in proteins. However, there has been limited integrated protein analysis in tick hemolymph thus far. Moreover, there are difficulties in differentiating tick-derived proteins from the host source. The aim of this study was to profile the tick/host protein components in the hemolymph of Haemaphysalis flava.Entities:
Keywords: Cystatin; Enzyme; Enzyme inhibitors; Hemolymph; Microplusin; Serpin; Tick; Vitellogenin
Mesh:
Substances:
Year: 2022 PMID: 35610668 PMCID: PMC9128142 DOI: 10.1186/s13071-022-05287-7
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 4.047
Fig. 1Sodium dodecyl sulfate–polyacrylamide gel electrophoresis analysis of proteins from Haemaphysalis flava hemolymph. M1, M2 = markers (kDa); 1, 2, 3 = three replicates of proteins from the H. flava hemolymph
High-confidence proteins from the host (Erinaceus europaeus) identified in hemolymph of Haemaphysalis flava ticks
| Protein overview | No. of unique peptides | Coverage (%) | Identity (%) | iBAQ (× 106) |
|---|---|---|---|---|
| P01949, hemoglobin subunit α, | 8 | 64.5 | 64.5 | 271.90 ± 59.13 |
| A0A1S3WPY1, hemoglobin subunit β, | 11 | 74.8 | 74.8 | 257.22 ± 55.55 |
| A0A1S2ZRW6, serum albumin, | 38 | 65.8 | 65.8 | 112.09 ± 27.87 |
| A0A1S3W2S7, serotransferrin-like, | 33 | 59.3 | 59.3 | 17.93 ± 4.42 |
| A0A1S3W634, ubiquitin-like, | 2 | 32.5 | 32.5 | 17.77 ± 4.71 |
| A0A1S3WFY0, haptoglobin, | 9 | 29.5 | 29.5 | 8.28 ± 2.12 |
| A0A1S3WJ22, α-1-antitrypsin-like protein, | 2 | 20.4 | 7 | 3.86 ± 0.87 |
| A0A1S3WR78, histone H2B, | 2 | 20.8 | 20.8 | 2.52 ± 0.63 |
| Q9TS49, apolipoprotein A-I, | 3 | 13.7 | 13.7 | 2.21 ± 0.68 |
| A0A1S3WDL1, C3-β, | 6 | 14.7 | 5.8 | 1.84 ± 0.51 |
| A0A1S3W909, tubulin β chain, | 5 | 15.9 | 15.9 | 1.77 ± 0.37 |
| A0A1S3WJA6, fibrinogen γ chain, | 4 | 14.5 | 14.5 | 1.46 ± 0.38 |
| A0A1S3W2L2, α-2-macroglobulin-like, | 13 | 12.4 | 12.4 | 1.34 ± 0.38 |
| A0A1S3AIG2, carbonic anhydrase, | 3 | 11.5 | 11.5 | 1.21 ± 0.30 |
| A0A1S3A1I2, hemopexin, | 3 | 8.4 | 8.4 | 0.86 ± 0.11 |
| A0A1S2ZF33, HSP90-α, | 4 | 7.1 | 7.1 | 0.80 ± 0.12 |
| A0A1S3A559, fibrinogen α chain, | 4 | 6.5 | 6.5 | 0.74 ± 0.21 |
| A0A1S3WJK5, fibrinogen β chain, | 4 | 8.6 | 8.6 | 0.71 ± 0.37 |
Fig. 2GO analysis of tick-derived proteins in hemolymph. The top ten GO terms of each category are as indicated
High-confidence tick proteins with reported functions in the hemolymph of H. flava ticks
| No. | Protein | Alignment | iBAQ (× 106) | ||||
|---|---|---|---|---|---|---|---|
| ID | Length (amino acids) | Entry and overview | Score | Identity (%) | |||
| I. Enzymes | |||||||
| 1 | Cl-k.18156 ① | 376 | L7M876, tick serine protease, | 0 | 1897 | 84.6 | 5.96 ± 1.32 |
| 2 | Cl-k.17502 ① | 484 | A0A131Z7A0, tick serine protease, | 0 | 1451 | 67.8 | 0.39 ± 0.04 |
| 3 | Cl-k.19217 ① | 437 | A0A1E1X8K7, serine protease, | 0 | 1907 | 85.1 | 2.13 ± 0.47 |
| 4 | Cl-k.19341 | 348 | A1IHG0, longipain, | 0 | 1814 | 93.5 | 7.34 ± 1.74 |
| 5 | Cl-k.18108 | 443 | A0A097CK68, enolase, | 0 | 2233 | 99.5 | 1.16 ± 0.35 |
| 6 | Cl-k.14381 | 507 | A0A6M2D6D9, serine carboxypeptidase, | 0 | 2115 | 83.6 | 0.49 ± 0.15 |
| 7 | Cl-k.18093 | 164 | A0A131XJQ8, metalloproteinase, | 1.7E−91 | 686 | 75.0 | (7) 221.26 ± 58.79 |
| 8 | Cl-k.18993 | 398 | Q2WFX6, aspartic protease, | 0 | 1990 | 95.9 | 1.47 ± 0.34 |
| 9 | Cl-k.7217 | 397 | A0A034WWI5, heme-binding aspartic peptidase, | 0 | 1343 | 68.0 | 3.03 ± 0.93 |
| 10 | Cl-k.14313 | 561 | A0A1E1XAU4, cysteine proteinase, | 0 | 2602 | 84.4 | 5.24 ± 1.17 |
| 11 | Cl-k.18480 | 326 | A0A023FWK4, cathepsin L, | 0 | 1604 | 88.7 | 99.93 ± 26.58 |
| 12 | Cl-k.24797 | 110 | A0A023GJU1, cathepsin C, | 2.6E−70 | 563 | 92.7 | 2.08 ± 0.83 |
| 13 | Cl-k.18626 | 416 | L7M0J1, phospholipase a2, | 0 | 1704 | 80.1 | 25.19 ± 5.41 |
| 14 | Cl-k.30316 ② | 566 | Q9U6M8, carboxylic ester hydrolase, | 5.1E−171 | 1290 | 47.3 | 10.59 ± 2.67 |
| 15 | Cl-k.24717 ② | 564 | A0A6M2CHI4, carboxylic ester hydrolase, | 0 | 1366 | 49.7 | 0.25 ± 0.05 |
| 16 | Cl-k.18635 | 521 | A5LHV9, disulfide isomerase, | 0 | 2514 | 96.2 | 1.74 ± 0.43 |
| 17 | Cl-k.17461 | 163 | F2Z7L0, lysozyme, | 3.1E−70 | 544 | 87.1 | 2.44 ± 0.86 |
| 18 | Cl-k.17638 | 397 | G8C7A0, lysosomal acid phosphatase, | 0 | 1878 | 93.5 | 75.50 ± 18.32 |
| 19 | Cl-k.18136 | 233 | Q6JVN0, glutathione S-transferase, | 3.5E−159 | 1144 | 93.7 | 1.74 ± 0.50 |
| 20 | Cl-k.18835 | 526 | A0A131YK94, superoxide dismutase (Cu–Zn), | 0 | 1475 | 61.8 | 18.83 ± 4.63 |
| 21 | Cl-k.19315 ③ | 316 | A0A131YMH9, chitinase, | 0 | 1777 | 85.6 | 1.46 ± 0.44 |
| 22 | Cl-k.18448 ③ | 536 | A0A023FND8, chitinase, | 0 | 1919 | 80.3 | 21.40 ± 4.31 |
| 23 | Cl-k.17863 | 367 | A0A286R6W4, fructose-bisphosphate aldolase, | 0 | 1796 | 94.2 | 2.26 ± 0.57 |
| 24 | Cl-k.35642 | 331 | A0A1E1X9Y4, alpha-L-fucosidase, | 0 | 1414 | 81.7 | 1.87 ± 0.38 |
| 25 | Cl-k.18180 | 430 | A0A2P1DPZ4, glyceraldehyde-3-phosphate dehydrogenase, | 0 | 1730 | 100 | 2.37 ± 0.62 |
| 26 | Cl-k.17933 | 549 | A0A6M2CTD4, ATP synthase subunit beta, | 0 | 2628 | 96.3 | 0.39 ± 0.02 |
| II. Enzyme inhibitors | |||||||
| 27 | Cl-k.20245 ④ | 256 | A0A5P8H6S1, serpin-a, | 9.3E−97 | 753 | 61.9 | 55.88 ± 13.09 |
| 28 | Cl-k.17714 ④ | 415 | A0A5P8H6S1, serpin-a, | 6.9E−169 | 1246 | 63.4 | 0.25 ± 0.24 |
| 29 | Cl-k.16905 ④ | 143 | A0A5P8H6S1, serpin-a, | 6.4E−49 | 422 | 61.8 | 32.01 ± 6.67 |
| 30 | Cl-k.18212 ④ | 427 | A0A5P8H6S1, serpin-a, | 0 | 1727 | 87.5 | 45.04 ± 10.59 |
| 31 | Cl-k.19946 ④ | 406 | Q75Q63, serpin-2 , | 0 | 1686 | 82.4 | 11.48 ± 2.66 |
| 32 | Cl-k.16646 ④ | 201 | A0A6M2E637, tick serpins 8, | 7.5E−68 | 555 | 63.0 | ⑻ 178.59 ± 44.58 |
| 33 | Cl-k.22217 ④ | 398 | A0A023GN51, tick serpins 13, | 9.5E−165 | 1216 | 61.8 | 38.49 ± 10.90 |
| 34 | Cl-k.14429 | 421 | A0A023G8Z1, serine proteinase inhibitor, | 0 | 1409 | 65.5 | 71.47 ± 17.26 |
| 35 | Cl-k.18644 ⑤ | 229 | A0A224YJB7, α2-macroglobulin splicing variant, | 3.7E−141 | 1119 | 91.7 | ⑸ 435.08 ± 100.49 |
| 36 | Cl-k.18677 ⑤ | 1142 | A0A1E1XEL3, α-macroglobulin, | 0 | 5401 | 89.6 | ⑹ 243.02 ± 53.71 |
| 37 | Cl-k.19779 ⑤ | 1820 | A0A1E1XL07, α-macroglobulin, | 0 | 6650 | 76.1 | 1.10 ± 0.27 |
| 38 | Cl-k.18726 et al. | 1915 | A0A023FNM2, α2-macroglobulin splicing variant, | 0 | 5819 | 78.9 | 35.72 ± 8.99 |
| 39 | Cl-k.18944 | 269 | A0A023GP16, Kazal-type serine protease inhibitor, | 5.8E−155 | 1123 | 84.0 | 8.02 ± 1.79 |
| 40 | Cl-k.12087 ⑥ | 183 | A0A6B9DA14, cystatin, | 0 | 757 | 100 | 15.11 ± 4.89 |
| 41 | Cl-k.17388 ⑥ | 185 | A0A3G6VF56, cystatin, | 1.9E−100 | 745 | 99.3 | 65.43 ± 15.54 |
| 42 | Cl-k.20981 ⑥ | 164 | A0A6M3YRY3, cystatin, | 4.2E−89 | 667 | 100 | 15.73 ± 4.93 |
| 43 | Cl-k.21288 | 228 | A0A023GEH6, thyropin, | 1.5E−94 | 723 | 60.0 | 22.19 ± 7.67 |
| 44 | Cl-k.23450 | 229 | A0A023GAB0, thyropin, | 2.2E−89 | 689 | 59.4 | 35.86 ± 8.77 |
| III. Immune-related proteins | |||||||
| 45 | Cl-k.18200 ⑦ | 84 | A0A6G5A751, microplusin, | 9.5E−31 | 260 | 54.8 | ⑴ 6514.56 ± 803.43 |
| 46 | Cl-k.18906 ⑦ | 134 | A0A6G5A751, microplusin, | 8.0E−34 | 295 | 52.5 | ⑷ 699.92 ± 23.27 |
| 47 | Cl-k.20235 ⑦ | 87 | A0A6G5A751, microplusin, | 2.1E−29 | 266 | 46.2 | 61.60 ± 17.16 |
| 48 | Cl-k.3924 | 78 | A0A2D1CLH7, defensin DFS2, | 2.1E−48 | 361 | 83.6 | 11.98 ± 3.53 |
| 49 | Cl-k.23590 ⑧ | 1612 | A0A131ZDX3, TIL domain-containing protein, | 0 | 7053 | 77.0 | 11.48 ± 2.56 |
| 50 | Cl-k.13586 ⑧ | 2610 | A0A131Z678, TIL domain-containing protein, | 0 | 8535 | 77.2 | 9.72 ± 2.21 |
| 51 | Cl-k.18775 ⑧ | 2252 | A0A131YJS1, TIL domain-containing protein, | 0 | 8966 | 68.9 | 1.42 ± 0.30 |
| 52 | Cl-k.25067 ⑧ | 109 | A0A6M2CNI0,TIL domain-containing protein, | 4.1E−39 | 329 | 69.9 | 26.91 ± 4.60 |
| 53 | Cl-k.18521 ⑨ | 235 | F0J8I6, ixoderin, | 5.4E−93 | 707 | 66.3 | 6.23 ± 1.40 |
| 54 | Cl-k.17959 ⑨ | 313 | A0A1E1XEF5, ixoderin, | 5.7E−153 | 1118 | 73.8 | 6.92 ± 1.81 |
| 55 | Cl-k.19166 | 177 | A0A6M2D1K3, C2b, | 6.9E−55 | 488 | 62.3 | 2.75 ± 0.88 |
| 56 | Cl-k.21838 | 428 | A0A7L9DI94, C3, | 1.0E−134 | 1104 | 50.9 | 10.48 ± 2.55 |
| 57 | Cl-k.14141 | 152 | A0A224Z7V2, serum amyloid A protein, | 1.4E−77 | 592 | 72.7 | 28.19 ± 6.81 |
| 58 | Cl-k.17842 | 332 | A0A0S3Q1T5, leucine-rich repeat containing protein, | 0 | 1464 | 90.1 | 19.96 ± 4.17 |
| 59 | Cl-k.18342 | 233 | A0A0M3TC17, AV422, | 8.4E−171 | 1221 | 100 | 12.15 ± 2.84 |
| 60 | Cl-k.18520 ⑩ | 181 | Q08G07, Hq05, | 1.1E−129 | 940 | 97.2 | 6.53 ± 1.43 |
| 61 | Cl-k.18575 ⑩ | 180 | G3BJU6, immunogenic protein, | 4.5E−120 | 877 | 93.9 | 16.62 ± 4.03 |
| IV. Transporters | |||||||
| 62 | Cl-k.25224 ⑪ | 1538 | Q5EG54, Vg, | 0 | 5360 | 67.5 | 0.21 ± 0.10 |
| 63 | Cl-k.16576 ⑪ | 686 | E1CAX9, vitellogenin-1, | 0 | 1248 | 98.5 | 126.50 ± 31.13 |
| 64 | Cl-k.19213-k18886 ⑪ | 351 | B1B544, vitellogenin-2, | 8.7E−86 | 732 | 98.3 | ⑶ 1606.10 ± 295.28 |
| 65 | Cl-k.18067 ⑪ | 463 | B1B544, vitellogenin-2, | 0 | 2072 | 85.1 | ⑵ 1829.13 ± 312.65 |
| 66 | Cl-k.19483 ⑪ | 1386 | B1B544, vitellogenin-2, | 0 | 4657 | 62.4 | ⑽ 138.31 ± 29.98 |
| 67 | Cl-k.16789 ⑪ | 114 | E1CAY0, vitellogenin-3, | 3.1E−62 | 535 | 85.7 | 95.40 ± 25.38 |
| 68 | Cl-k.18851-18114 ⑪ | 2279 | G9M4L6, vitellogenin B, | 0 | 13,028 | 85.9 | 63.60 ± 12.52 |
| 69 | Cl-k.21299 | 207 | M5AYG7, ferritin 2, | 9.9E−133 | 965 | 93.5 | 22.51 ± 4.62 |
| 70 | Cl-k.19103 | 152 | A0A023G718, fatty acid-binding protein, | 4.6E−83 | 628 | 85.4 | 15.26 ± 2.76 |
| V. Muscle proteins | |||||||
| 71 | Cl-k.18720 | 877 | J7LVN2, paramyosin, | 0 | 4196 | 98.2 | 0.53 ± 0.13 |
| 72 | Cl-k.18460 | 424 | A8E4J9, calreticulin, | 0 | 2247 | 99.5 | 2.42 ± 0.76 |
| 73 | Cl-k.18394 | 52 | A0A131ZAE8, tropomyosin, | 0 | 1423 | 93.2 | 3.76 ± 1.07 |
| 74 | Cl-k.18452 | 83 | A0A0N6X2B1, muscle LIM protein, | 7.8E−57 | 417 | 95.8 | 4.98 ± 1.14 |
| VI. Heat shock proteins | |||||||
| 75 | Cl-k.18505 ⑫ | 655 | A0A097A1J8, heat shock 70 kDa protein 8, | 0 | 3290 | 100 | 2.09 ± 0.55 |
| 76 | Cl-k.18161 ⑫ | 683 | E4W3Z2, heat shock 70 kDa protein 5, | 0 | 3317 | 99.1 | 0.45 ± 0.22 |
| Other | |||||||
| Cl-k.18334 | 255 | A0A023FPM9, glycine-rich secreted cement protein, | 1.1E−118 | 884 | 74.0 | ⑼ 170.44 ± 38.51 | |
Proteins sharing the same number in the Protein ID column belong to the same family. Length indicates the number of amino acid residues of protein fractions detected by MS. The number in the iBAQ column indicates the top 10 most abundant peptides detected by MS